Results 161 to 170 of about 251,409 (391)
A note on the prothrombin time abnormality in the patients with amebic liver abscess [PDF]
Amebic liver abscess is reported worldwide and can present with a a wide spectrum of clinical manifetations. Similar to the other liver diseases, the prothrombin time abnormality can be seen in the patients with amebic liver abscess.
Suwansaksri, Jamsai+2 more
core +1 more source
This study have loaded chiral gold nanoclusters onto the inner and outer surfaces of ZIF and uncovers the biodistribution, metabolic variances, and therapeutic mechanism of chiral nanoparticles, providing deep insights into the nanobiological effects of chiral anti‐inflammatory nanomedicines in PD therapy for future clinical transformation.
Junyang Chen+7 more
wiley +1 more source
SERUM TRANSAMINASE ACTIVITY IN UNCOMPLICATED AND COMPLICATED PREGNANCY AND IN NEWBORNS [PDF]
N. E. Borglin
openalex +1 more source
A theranostic nanoplatform is formulated with NIR‐II emissive lipophilic cyanine dye IRC18 to intercalate into genetically engineered IL12/CSF1R‐macrophage membrane‐liposome hybrid nanovesicles, which assists to achieve blood–brain barrier crossing, glioblastoma targeting, NIR‐II fluorescence imaging, image‐guided membrane‐targeted mild photothermal ...
Pengfei Chen+10 more
wiley +1 more source
Serum Transaminase Levels in Experimental Pulmonary Infarction [PDF]
Clarence M. Agress+2 more
openalex +1 more source
Microsatellite‐stable (MSS) colorectal cancer (CRC) resists immunotherapy. PRMT5 inhibition enhances CPT‐11 sensitivity, inducing a PMS2‐deficient‐like state and cytosolic dsDNA release, which activates the cGAS‐STING pathway to promote anti‐tumor immunity. However, this combination therapy upregulates TIGIT expression on CD8+ T cells, and the addition
Jiang Zhu+10 more
wiley +1 more source
Enzyme Activation in Wheat Grains in Relation to Water Content. Glutamic Acid—Alanine Transaminase, and Glutamic Acid Decarboxylase. [PDF]
P. Linko, Max Milner
openalex +1 more source
Natural transaminase fusions for biocatalysis
This work describes novel transaminase fusions, with potential for converting fatty acids into amines and more complex natural products.
Luba Prout+2 more
openaire +3 more sources
Dipyridamole Acts as Clinical Ferroptosis Inhibitor to Prevent from Tissue Injury
Dipyridamole acts as a clinically used compound to suppress ferroptosis. Dipyridamole down‐regulates the expression of RNF126, which is an E3 ligase to ubiquitinate SLC7A11 for proteasome degradation. The deficiency of SLC7A11 largely abolishes the protective role of dipyridamole both in vitro and in vivo.
Xiao Zhuang+22 more
wiley +1 more source